Trials / Completed
CompletedNCT02166424
The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Tokyo Medical University · Academic / Other
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.
Detailed description
Maternal depression can have a significant harmful influence on both mothers and children. Considering the possibility of adverse effects of antidepressants and previous meta-analyses showing the positive effects of omega-3 polyunsaturated fatty acids (PUFAs) supplementation in reducing depressive symptoms, omega-3 PUFAs may provide a safe strategy. The investigators evaluate efficacy and safety of omega-3 PUFAs for pregnant women with depressive symptoms. (Participants who skipped taking supplements for more than 7 days will be excluded from a per protocol analysis.)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 polyunsaturated fatty acids | |
| DIETARY_SUPPLEMENT | Olive oil |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2017-08-01
- Completion
- 2017-12-01
- First posted
- 2014-06-18
- Last updated
- 2017-12-21
Locations
4 sites across 2 countries: Japan, Taiwan
Source: ClinicalTrials.gov record NCT02166424. Inclusion in this directory is not an endorsement.